| Literature DB >> 20497537 |
Shih-Kuang Yang1, Yu-Chao Wang, Chun-Cheih Chao, Yung-Jen Chuang, Chung-Yu Lan, Bor-Sen Chen.
Abstract
BACKGROUND: Development in systems biology research has accelerated in recent years, and the reconstructions for molecular networks can provide a global view to enable in-depth investigation on numerous system properties in biology. However, we still lack a systematic approach to reconstruct the dynamic protein-protein association networks at different time stages from high-throughput data to further analyze the possible cross-talks among different signaling/regulatory pathways.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20497537 PMCID: PMC2889840 DOI: 10.1186/1755-8794-3-19
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Figure 1Schematic diagram for reconstructing the protein-protein association. This diagram shows the basic concept of the reconstruction of protein-protein association. On the protein level, the interactions between proteins from the well-known database and experimental data were extracted. However, this kind of interactions only reflects all possible static connections without stimulus-specific response or temporal changes. Our model includes the gene expression patterns from different time course to infer the dynamic protein-protein associations and networks, suggesting a more significant and realistic method for network reconstruction of the living organism.
Figure 2Flowchart of the proposed method to construct the protein-protein association network (PPAN). This flowchart depicts the process to construct the protein-protein association network (PPAN) and the afterward investigations in this study. The four key steps of PPAN construction are described in details in the text. The rough PPAN is set up from steps (1) and (2), and the refinement is then performed in steps (3) and (4) to obtain the refined PPAN.
Human protein candidates and their pathway catalogues in this study.
| TNF | IL-1 | MyD88-dependent TLR-4 | MyD88-independent TLR-4 | Negative regulators |
|---|---|---|---|---|
| TNF | IL1α | MyD88 | TLR4 | A20 |
| TNFR1 | IL1β | TIRAP | TRAM | CYLD |
| TNFR2 | IL1R1 | CD14 | TRIF | FLN29 |
| TRADD | IL1R2 | PELI2 | TRAF3 | IRAK3 |
| FADD | TOLLIP | IRAK4 | TANK | NOD2 |
| GRB2 | ST2L | IRAK1 | TBK1 | RIP3 |
| SOS1 | PELI1 | NIK | IKKε | PTPN11 |
| CAV1 | ECSIT | BCL10 | IRF3 | RNF216 |
| CASP8 | SARM | |||
| TRAF2 | SIGIRR | |||
| TRAF5 | SOCS1 | |||
| TTRAP | TMED1 | |||
| TRAF6 | TNIP3 | |||
| RIP | TRAF4 | |||
| MEKK3 | UBE2N | |||
| TAK1 | ||||
| TAB1 | ||||
| TAB2 | ||||
| IKKα | ||||
| IKKβ | ||||
| IKKγ |
Proteins in the cross-talk analysis are classified into three major pathways, including TNFα, IL-1, TLR-4 (for both MyD88-dependent and MyD88-independent) pathways. The full names of these proteins are listed in the following. BCL10: B-cell CLL/lymphoma 10, NOD2: nucleotide-binding oligomerization domain containing 2, CASP8: caspase 8, apoptosis-related cysteine peptidase, CAV1: caveolin 1, caveolae protein, 22 kDa, CD14: CD14 molecule, IKKα: conserved helix-loop-helix ubiquitous kinase, CYLD: cylindromatosis (turban tumor syndrome), FADD: Fas (TNFRSF6)-associated via death domain, GRB2: growth factor receptor-bound protein 2, IKKβ: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, IKKε: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon, IKKγ: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, IL1α: interleukin 1, alpha, IL1β: interleukin 1, beta, IL1R1: interleukin 1 receptor, type I, IL1R2: interleukin 1 receptor, type II, ST2L: interleukin 1 receptor-like 1, IRAK1: interleukin-1 receptor-associated kinase 1, IRAK3: Interleukin-1 receptor-associated kinase 3, IRAK4: interleukin-1 receptor-associated kinase 4, IRF3: interferon regulatory factor 3, NIK: mitogen-activated protein kinase kinase kinase 14, MEKK3: mitogen-activated protein kinase kinase kinase 3, TAK1: Mitogen-activated protein kinase kinase kinase 7, TAB1: mitogen-activated protein kinase kinase kinase 7 interacting protein 1, TAB2: mitogen-activated protein kinase kinase kinase 7 interacting protein 2, MyD88: myeloid differentiation primary response gene (88), PELI1: pellino homolog 1 (Drosophila), PELI2: pellino homolog 2 (Drosophila), PTPN11: protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1), RIP: receptor (TNFRSF)-interacting serine-threonine kinase 1, RIP3: receptor-interacting serine-threonine kinase 3, SARM: sterile alpha and TIR motif containing 1, SIGIRR: single immunoglobulin and toll-interleukin 1 receptor (TIR) domain, ECSIT: ECSIT homolog (Drosophila), SOCS1: suppressor of cytokine signaling 1, SOS1: Son of sevenless homolog 1 (Drosophila), TANK: TRAF family member-associated NFKB activator, TBK1: TANK-binding kinase 1, TIRAP: toll-interleukin 1 receptor (TIR) domain containing adaptor protein, TLR4: toll-like receptor 4, TMED1: transmembrane emp24 protein transport domain containing 1, TNF: tumor necrosis factor (TNF superfamily, member 2), A20: tumor necrosis factor, alpha-induced protein 3, TNFR1: tumor necrosis factor receptor superfamily, member 1A, TNFR2: tumor necrosis factor receptor superfamily, member 1B, TNIP3: TNFAIP3 interacting protein 3, TOLLIP: toll interacting protein, TRADD: TNFRSF1A-associated via death domain, TRAF2: TNF receptor-associated factor 2, TRAF3: TNF receptor-associated factor 3, TRAF4: TNF receptor-associated factor 4, TRAF5: TNF receptor-associated factor 5, TRAF6: TNF receptor-associated factor 6, FLN29: TRAF-type zinc finger domain containing 1, TRAM: toll-like receptor adaptor molecule 2, RNF216: TRIAD3 protein, TRIF: toll-like receptor adaptor molecule 1, TTRAP: TRAF and TNF receptor associated protein, UBE2N: ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast)
Figure 3Counting for the cross-talk ranking values (CTRVs). CTRV is a ranking value which reflects the potential of a protein in connection with multiple pathways. (A) All proteins connected with protein A belong to the same pathway A. In this case, the CTRV of protein A will not be changed. (B) If protein A connects with protein B, which belongs to a different pathway, then both CTRVs of protein A and B will be added by one.
Figure 4Refined PPANs for HUVEC under TNFα stress at different time stages. The illustration shows a time-series layout for each refined PPANs from 0 to 8 hour. Every refined PPAN is identified via a set of gene expression profile with five data points. In order to distinguish proteins involved in different signaling cascades, proteins belong to the same pathway are labeled with the same color. The progression of ever-changing associations obviously reveals that new connections continuously emerge, reflecting the fact that new signaling modules and function communities are involved in the endothelial inflammatory response to the TNFα stimulus. In addition, the top five hubs with highly connected degree are marked with larger font size. The numbers of nodes, edges and the highly connected hubs at different time stages are outlined in Table 2.
Statistics of the TNFα-induced protein-protein association networks of HUVEC.
| Duration | Nodes | Edges | Highly connected proteins | ||||
|---|---|---|---|---|---|---|---|
| 56 | 144 | TRAF2 | IRAK1 | TRAF6 | IKKα | IKKβ | |
| 56 | 156 | TRAF2 | TRAF6 | IRAK1 | RIP | TNFR1 | |
| 56 | 150 | IRAK1 | TRAF6 | TRAF2 | IKKα | RIP | |
| 55 | 152 | TRAF2 | IKKα | TNFR1 | IRAK1 | TRAF6 | |
| 56 | 151 | IRAK1 | TRAF2 | TRAF6 | RIP | TNFR1 | |
| 56 | 156 | TRAF2 | TRAF6 | RIP | IKKα | IRAK1 | |
Summary of the reconstruction of protein-protein association networks at different time stages. Proteins with maximal protein-protein associations are sorted in this table. These proteins are usually considered as the hubs which will be involved in several biological functions and play important roles in the signaling network.
Figure 5Investigations of the (A) TNFα-related pathway and (B) IL-1/TLR4-related pathways. Protein components which are ultimately responsible for the trigger of an inflammatory function are labeled with the same color in the pathway, and the thicker red edges represent the associations listed in Supplementary Table S2 [Additional file 3] and Supplementary Table S3 [Additional file 4].
Cross-talk ranking values (CTRVs) and link values of significant proteins in PPAN.
| 1 | IRAK1 | 108 | 140 | 31 | IL1R1 | 21 | 21 |
| 2 | TRAF6 | 83 | 124 | 32 | FADD | 19 | 55 |
| 3 | NIK | 77 | 89 | 33 | GRB2 | 18 | 46 |
| 4 | A20 | 61 | 61 | 34 | TAK1 | 17 | 66 |
| 5 | MYD88 | 59 | 107 | 35 | SOCS1 | 17 | 17 |
| 6 | TRAF2 | 58 | 198 | 36 | TRIF | 16 | 54 |
| 7 | IKKα | 55 | 83 | 37 | TMED1 | 12 | 12 |
| 8 | SIGIRR | 53 | 73 | 38 | CASP8 | 10 | 87 |
| 9 | TLR4 | 53 | 53 | 39 | TAB2 | 10 | 53 |
| 10 | IKKγ | 52 | 84 | 40 | CAV1 | 10 | 44 |
| 11 | IKKβ | 47 | 97 | 41 | TAB1 | 9 | 44 |
| 12 | BCL10 | 43 | 62 | 42 | TTRAP | 8 | 8 |
| 13 | UBE2N | 41 | 41 | 43 | ECSIT | 8 | 50 |
| 14 | IRAK4 | 38 | 112 | 44 | CYLD | 6 | 6 |
| 15 | RIP | 38 | 57 | 45 | TNF | 0 | 48 |
| 16 | TRAF3 | 37 | 57 | 46 | TNFR2 | 0 | 39 |
| 17 | IRAK3 | 36 | 36 | 47 | IKKε | 0 | 29 |
| 18 | ST2L | 32 | 32 | 48 | PELI2 | 0 | 19 |
| 19 | TNIP3 | 32 | 32 | 49 | IL1B | 0 | 18 |
| 20 | PTPN11 | 31 | 31 | 50 | MEKK3 | 0 | 18 |
| 21 | TIRAP | 29 | 40 | 51 | TRAM | 0 | 18 |
| 22 | TRAF4 | 27 | 27 | 52 | IL1A | 0 | 17 |
| 23 | TOLLIP | 26 | 47 | 53 | IL1R2 | 0 | 17 |
| 24 | RNF216 | 25 | 25 | 54 | TRAF5 | 0 | 17 |
| 25 | TNFR1 | 24 | 111 | 55 | SOS1 | 0 | 10 |
| 26 | RIP3 | 23 | 93 | 56 | IRF3 | 0 | 9 |
| 27 | TRADD | 23 | 32 | 57 | NOD2 | 0 | 0 |
| 28 | TBK1 | 22 | 39 | 58 | CD14 | 0 | 0 |
| 29 | PELI1 | 21 | 49 | 59 | SARM1 | 0 | 0 |
| 30 | TANK | 21 | 40 | 60 | FLN29 | 0 | 0 |
To integrate the information from the complex PPANs, the cross-talk ranking values (CTRVs) at different time stages are summed up for each protein. In contrast with CTRVs, the values of link represent the total number of protein-protein associations at six time stages of each protein. It reveals that not all nodes with high connective degree will also have high CTRVs such as CASP8.
Proteins with high cross-talk ranking values at different time stages.
| Duration | Top ranked proteins | ||||
|---|---|---|---|---|---|
| IRAK1 | NIK | IKKα | TRAF6 | IKKβ | |
| TRAF6 | IRAK1 | NIK | A20 | TRAF2 | |
| IRAK1 | TRAF6 | NIK | A20 | TRAF2 | |
| IRAK1 | NIK | TRAF6 | A20 | IKKγ | |
| IRAK1 | TRAF6 | NIK | TRAF2 | A20 | |
| IRAK1 | NIK | TRAF6 | IKKα | A20 | |
In contract with Table 2, proteins with maximal CTRVs are listed here. Among these highly ranked proteins, NIK and A20 are considered as two core elements in the signaling network by the analysis of CTRV, but their importance is not exhibited in Table 2. This reveals that our proposed method generates a new insight into the evaluation of cross-talk candidates.
Figure 6Dynamic progression of refined PPANs for HUVEC under TNFα stress. Time series refined PPANs under the TNFα stress from 0 to 3 hours are presented to monitor the dynamic properties of association progression. Positions of nodes are rearranged based on approximately up/down-stream relationships of the proteins. The general signaling proteins are shown as elliptic nodes; square nodes represent the receptor proteins and diamond nodes represent the possible negative regulator proteins. Dash gray lines represent the associations which are related to negative regulators. The levels of gene expression are indicated by the node color, in which the red color means the gene expression at that time is higher than its gene expression without TNFα treatment and the green color means the gene expression at that time is lower than its gene expression without TNFα treatment. The complete and pellucid time series diagrams from 0 to 8 hours are presented in Supplementary Figures [Additional file 5].
Figure 7Bow-tie structure under TNFα stress for multiple pathways in the inflammatory system. A specific architecture of TNFα-induced endothelial inflammatory system is extracted from the PPAN in which the core elements of the bow-tie structure are identified via the CTRV ranking algorithm. Upon ligand binding, various types of receptors on the cell membrane trigger different signaling pathways and activate the downstream corresponding transcription factors such as NFκB. NFκB then regulates the expression of genes involved in inflammatory responses. These kinds of gene expression will induce some particular biological mechanisms helping the host to defense the invading microorganisms. In addition, the translation of cytokines and some negatively regulatory proteins will play roles of feedback control to coordinate the balance in immunity.